• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2型糖尿病患者视力损害的患病率及相关危险因素:桑卡拉奈特拉亚糖尿病视网膜病变流行病学与分子遗传学研究(SN-DREAMS,报告16)

Prevalence of Visual Impairment and Associated Risk Factors in Subjects with Type II Diabetes Mellitus: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study (SN-DREAMS, Report 16).

作者信息

Rani Padmaja Kumari, Raman Rajiv, Gella Laxmi, Kulothungan Vaitheeswaran, Sharma Tarun

机构信息

Shri Bhagwan Mahavir Vitreoretinal Services, 18 College Road, Sankara Nethralaya, Chennai, Tamil Nadu, India.

出版信息

Middle East Afr J Ophthalmol. 2012 Jan;19(1):129-34. doi: 10.4103/0974-9233.92129.

DOI:10.4103/0974-9233.92129
PMID:22346128
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3277010/
Abstract

PURPOSE

To report the prevalence of visual impairment (VI) and the associated risk factors in type II diabetic subjects.

MATERIALS AND METHODS

The study included type II diabetes mellitus subjects who were enrolled from a cross-sectional study. Participants underwent biochemical testing and comprehensive ocular examination including stereo fundus photography. The VI was defined based on the World Health Organization criteria.

RESULTS

The prevalence of VI was 4% in the cohort. The risk factors associated with the presence of VI included a female gender, age greater than 60 years, low socio-economic status, hypertension, microalbuminuria, macroalbuminuria, neuropathy, use of insulin and alcohol. Various ocular risk factors are nuclear sclerosis, subjects who have undergone cataract surgery, myopia and sight-threatening diabetic retinopathy (STDR). After adjusting for the factors using stepwise logistic regression analysis, hypertension, use of alcohol, post-cataract surgery and myopia were not risk factors. Stepwise logistic regression analysis indicated that VI was higher among subjects older than 60 years (odds ratio (OR): 4.95 [2.67-9.15]) and those who belonged to a low socio-economic status (OR: 2.91 [1.24-6.85]). The systemic risk factors for VI included microalbuminuria (OR: 2.91 [1.59-5.33]), macroalbuminuria (OR: 4.65 [1.57-13.77]) and presence of neuropathy (OR: 1.97 [1.09-3.59]) among subjects. Subjects with nuclear sclerosis (OR: 36.82 [11.12-112.36]) and presence of STDR (OR: 4.17 [1.54-11.29]) were at a higher risk of VI. Cataract was the most common cause of VI in the cohort.

CONCLUSION

Visual impairment, among type II diabetic subjects (4%), is a major public health problem that needs to be addressed. Cataract is the most common reversible cause of vision impairment in this population.

摘要

目的

报告2型糖尿病患者视力损害(VI)的患病率及其相关危险因素。

材料与方法

本研究纳入了一项横断面研究中的2型糖尿病患者。参与者接受了生化检测和包括立体眼底摄影在内的全面眼部检查。视力损害根据世界卫生组织标准定义。

结果

该队列中视力损害的患病率为4%。与视力损害相关的危险因素包括女性、年龄大于60岁、社会经济地位低、高血压、微量白蛋白尿、大量白蛋白尿、神经病变、使用胰岛素和饮酒。各种眼部危险因素包括核硬化、接受过白内障手术的患者、近视和威胁视力的糖尿病视网膜病变(STDR)。在使用逐步逻辑回归分析对这些因素进行校正后,高血压、饮酒、白内障手术后和近视不是危险因素。逐步逻辑回归分析表明,60岁以上的患者(优势比(OR):4.95 [2.67 - 9.15])和社会经济地位低的患者(OR:2.91 [1.24 - 6.85])视力损害的发生率更高。视力损害的全身危险因素包括微量白蛋白尿(OR:2.91 [1.59 - 5.33])、大量白蛋白尿(OR:4.65 [1.57 - 13.77])以及患者存在神经病变(OR:1.97 [1.09 - 3.59])。患有核硬化的患者(OR:36.82 [11.12 - 112.36])和存在STDR的患者(OR:4.17 [1.54 - 11.29])发生视力损害的风险更高。白内障是该队列中视力损害最常见的原因。

结论

2型糖尿病患者中存在视力损害(4%),这是一个需要解决的主要公共卫生问题。白内障是该人群中视力损害最常见的可逆转原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cff6/3277010/91bfd564da45/MEAJO-19-129-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cff6/3277010/91bfd564da45/MEAJO-19-129-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cff6/3277010/91bfd564da45/MEAJO-19-129-g003.jpg

相似文献

1
Prevalence of Visual Impairment and Associated Risk Factors in Subjects with Type II Diabetes Mellitus: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study (SN-DREAMS, Report 16).2型糖尿病患者视力损害的患病率及相关危险因素:桑卡拉奈特拉亚糖尿病视网膜病变流行病学与分子遗传学研究(SN-DREAMS,报告16)
Middle East Afr J Ophthalmol. 2012 Jan;19(1):129-34. doi: 10.4103/0974-9233.92129.
2
Prevalence of posterior vitreous detachment in the population with type II diabetes mellitus and its effect on diabetic retinopathy: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study SN-DREAMS report no. 23.2 型糖尿病患者中后玻璃体脱离的患病率及其对糖尿病视网膜病变的影响:Sankara Nethralaya 糖尿病视网膜病变流行病学和分子遗传学研究 SN-DREAMS 报告第 23 号。
Jpn J Ophthalmol. 2012 May;56(3):262-7. doi: 10.1007/s10384-012-0134-7. Epub 2012 Apr 3.
3
Incidence, Progression, and Associated Risk Factors of Posterior Vitreous Detachment in Type 2 Diabetes Mellitus: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS II, Report No. 7).2型糖尿病患者玻璃体后脱离的发病率、进展及相关危险因素:桑卡拉奈特拉亚糖尿病视网膜病变流行病学和分子遗传学研究(SN-DREAMS II,报告编号7)
Semin Ophthalmol. 2017;32(2):191-197. doi: 10.3109/08820538.2015.1047959. Epub 2015 Jul 6.
4
Sankara Nethralaya-Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS 1): study design and research methodology.桑卡拉奈特拉亚糖尿病视网膜病变流行病学与分子遗传学研究(SN-DREAMS 1):研究设计与研究方法
Ophthalmic Epidemiol. 2005 Apr;12(2):143-53. doi: 10.1080/09286580590932734.
5
Foveal slope measurements in diabetic retinopathy: Can it predict development of sight-threatening retinopathy? Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study (SN-DREAMS II, Report no 8).糖尿病视网膜病变中的黄斑斜率测量:它能否预测威胁视力的视网膜病变的发展?桑卡拉奈特拉亚糖尿病视网膜病变流行病学与分子遗传学研究(SN-DREAMS II,报告编号8)。
Indian J Ophthalmol. 2015 Jun;63(6):478-81. doi: 10.4103/0301-4738.162578.
6
Impairment of Colour Vision in Diabetes with No Retinopathy: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study (SNDREAMS- II, Report 3).无视网膜病变的糖尿病患者的色觉损害:桑卡拉奈特拉亚糖尿病视网膜病变流行病学和分子遗传学研究(SNDREAMS-II,报告3)
PLoS One. 2015 Jun 8;10(6):e0129391. doi: 10.1371/journal.pone.0129391. eCollection 2015.
7
Albuminuria and Diabetic Retinopathy in Type 2 Diabetes Mellitus Sankara Nethralaya Diabetic Retinopathy Epidemiology And Molecular Genetic Study (SN-DREAMS, report 12).2 型糖尿病患者的白蛋白尿和糖尿病视网膜病变 Sankara Nethralaya 糖尿病视网膜病变流行病学和分子遗传学研究(SN-DREAMS,报告 12)。
Diabetol Metab Syndr. 2011 May 25;3(1):9. doi: 10.1186/1758-5996-3-9.
8
Prevalence and risk factors for diabetic microvascular complications in newly diagnosed type II diabetes mellitus. Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS, report 27).新诊断的 2 型糖尿病患者中糖尿病微血管并发症的患病率及其危险因素。Sankara Nethralaya 糖尿病视网膜病变流行病学和分子遗传学研究(SN-DREAMS,报告 27)。
J Diabetes Complications. 2012 Mar-Apr;26(2):123-8. doi: 10.1016/j.jdiacomp.2012.02.001. Epub 2012 Mar 24.
9
Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN--DREAMS III): study design and research methodology.桑卡尔纳眼科研究所糖尿病视网膜病变的流行病学和分子遗传学研究(SN--DREAMS III):研究设计和研究方法。
BMC Ophthalmol. 2011 Mar 24;11:7. doi: 10.1186/1471-2415-11-7.
10
Incidence and Progression of Diabetic Retinopathy in Urban India: Sankara Nethralaya-Diabetic Retinopathy Epidemiology and Molecular Genetics Study (SN-DREAMS II), Report 1.印度城市地区糖尿病视网膜病变的发病率与进展:桑卡拉奈特拉亚糖尿病视网膜病变流行病学与分子遗传学研究(SN-DREAMS II),报告1
Ophthalmic Epidemiol. 2017 Oct;24(5):294-302. doi: 10.1080/09286586.2017.1290257. Epub 2017 Mar 23.

引用本文的文献

1
Renal impairment may indicate postoperative low vision in young patients with proliferative diabetic retinopathy undergoing vitrectomy.肾功能损害可能预示着接受玻璃体切除术的增殖性糖尿病视网膜病变年轻患者术后视力低下。
Front Endocrinol (Lausanne). 2024 Jan 11;14:1321226. doi: 10.3389/fendo.2023.1321226. eCollection 2023.
2
The prevalence, incidence, and persistence of self-reported visual impairment among Chinese population with diabetes mellitus: evaluation from a nationally representative survey, 2015-2018.2015-2018 年中国糖尿病患者自我报告视力障碍的患病率、发病率和持续性:一项全国代表性调查的评估。
Front Public Health. 2023 Jun 15;11:978457. doi: 10.3389/fpubh.2023.978457. eCollection 2023.
3

本文引用的文献

1
Diabetes mellitus and visual impairment: national health and nutrition examination survey, 1999-2004.糖尿病与视力损害:1999 - 2004年美国国家健康与营养检查调查
Arch Ophthalmol. 2008 Oct;126(10):1421-7. doi: 10.1001/archopht.126.10.1421.
2
Rapid Assessment of Avoidable Blindness in India.印度可避免失明的快速评估
PLoS One. 2008 Aug 6;3(8):e2867. doi: 10.1371/journal.pone.0002867.
3
Relationship between visual impairment and eye diseases and visual function in Andhra Pradesh.安得拉邦视力损害与眼部疾病及视觉功能之间的关系。
Blindness among Patients with Type II Diabetes Mellitus Presenting to the Outpatient Department of Ophthalmology of a Tertiary Care Centre: A Descriptive Cross-sectional Study.
在一家三级护理中心的眼科门诊就诊的 2 型糖尿病患者中的失明情况:一项描述性横断面研究。
JNMA J Nepal Med Assoc. 2022 Oct 1;60(254):877-880. doi: 10.31729/jnma.7702.
4
Visual impairment and its predictors among people living with type 2 diabetes mellitus at Dessie town hospitals, Northeast Ethiopia: institution-based cross-sectional study.埃塞俄比亚东北德西镇医院 2 型糖尿病患者的视力障碍及其预测因素:基于机构的横断面研究。
BMC Ophthalmol. 2022 Feb 3;22(1):52. doi: 10.1186/s12886-022-02292-3.
5
Clinical profile and magnitude of diabetic retinopathy: An electronic medical record-driven big data analytics from an eye care network in India.临床特征与糖尿病视网膜病变的严重程度:来自印度眼科保健网络的电子病历驱动的大数据分析。
Indian J Ophthalmol. 2021 Nov;69(11):3110-3117. doi: 10.4103/ijo.IJO_1490_21.
6
Visual impairment and associated risk factors in patients with diabetes mellitus in Tavush and Armavir provinces of Armenia.亚美尼亚塔武什省和阿尔马维尔省糖尿病患者的视力障碍及相关危险因素。
Int Ophthalmol. 2022 Jan;42(1):47-56. doi: 10.1007/s10792-021-01998-5. Epub 2021 Aug 11.
7
Effects of Femtosecond Laser-Assisted Cataract Surgery on Macular and Choroidal Thickness in Diabetic Patients.飞秒激光辅助白内障手术对糖尿病患者黄斑和脉络膜厚度的影响。
Ophthalmol Ther. 2021 Mar;10(1):137-150. doi: 10.1007/s40123-020-00326-x. Epub 2021 Jan 19.
8
Improvement in distance and near visual acuities using low vision devices in diabetic retinopathy.糖尿病视网膜病变患者使用低视力设备后远视力和近视力的改善情况。
Indian J Ophthalmol. 2017 Oct;65(10):995-998. doi: 10.4103/ijo.IJO_52_17.
9
Four-year incidence and progression of visual impairment in a South Indian population with diabetes.南印度糖尿病患者视力损害的四年发病率及病情进展情况。
Indian J Ophthalmol. 2017 Jul;65(7):589-595. doi: 10.4103/ijo.IJO_520_16.
10
Association of alcohol intake with risk of diabetic retinopathy: a meta-analysis of observational studies.饮酒与糖尿病视网膜病变风险的关联:观察性研究的荟萃分析。
Sci Rep. 2017 Jan 31;7(1):4. doi: 10.1038/s41598-017-00034-w.
Ophthalmology. 2007 Aug;114(8):1552-7. doi: 10.1016/j.ophtha.2006.11.012.
4
Causes of blindness and visual impairment in urban and rural areas in Beijing: the Beijing Eye Study.北京城乡地区失明和视力损伤的病因:北京眼病研究
Ophthalmology. 2006 Jul;113(7):1134.e1-11. doi: 10.1016/j.ophtha.2006.01.035. Epub 2006 May 2.
5
Prevalence and causes of blindness in the rural population of the Chennai Glaucoma Study.钦奈青光眼研究中农村人口失明的患病率及病因
Br J Ophthalmol. 2006 Apr;90(4):407-10. doi: 10.1136/bjo.2005.081406.
6
Sankara Nethralaya-Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS 1): study design and research methodology.桑卡拉奈特拉亚糖尿病视网膜病变流行病学与分子遗传学研究(SN-DREAMS 1):研究设计与研究方法
Ophthalmic Epidemiol. 2005 Apr;12(2):143-53. doi: 10.1080/09286580590932734.
7
Global data on visual impairment in the year 2002.2002年全球视力损害数据。
Bull World Health Organ. 2004 Nov;82(11):844-51. Epub 2004 Dec 14.
8
Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.全球糖尿病患病率:2000年的估计数及2030年的预测数。
Diabetes Care. 2004 May;27(5):1047-53. doi: 10.2337/diacare.27.5.1047.
9
The measurement of SES in health research: current practice and steps toward a new approach.健康研究中社会经济地位(SES)的测量:当前实践与新方法的探索步骤
Soc Sci Med. 2003 Feb;56(4):769-84. doi: 10.1016/s0277-9536(02)00073-4.
10
Diabetic nephropathy.糖尿病肾病
Diabetes Care. 2003 Jan;26 Suppl 1:S94-8. doi: 10.2337/diacare.26.2007.s94.